Biotech China 2014
7th Annual In-House Counsel Forum on Government Regulation of Prescription Drug Pricing
New York Marriott East Side Hotel
525 Lexington Ave,
New York,, NY

Schedule of Presentations:

Tuesday, March 10, 2009
09:00:00 Interactive Workshop A – Contracting in a World Without AWP: Preparing for Contract Negotiations Using New Pricing Benchmarks
13:00:00 Interactive Workshop B – Master Class on International Drug Pricing: Understanding How Global Pricing and Reimbursement Systems Impact Overall Pricing Strategies Wayne Critchley
Wednesday, March 11, 2009
07:15:00 Registration and Continental Breakfast
08:15:00 Co-Chairs’ Opening Remarks Larri A Short, Ann Flaherty
08:30:00 Preparing for Potential Changes to AMP and Examining How Those Changes Will Affect the Pricing Sector Benjamin S Martin, Don L Bell, II
09:45:00 Morning Coffee Break
10:00:00 Navigating Compliance Obligations Under New TRICARE Regulations Constance A Wilkinson, Howard Crawford
11:15:00 Resolving Disputes with State Medicaid Programs and CMS
12:15:00 Networking Luncheon
13:30:00 Breakout Session 1 : (A) Tracking the Evolution of MDL 1456 Tina M Tabacchi, Michael L Koon, William F Cavanaugh, Jr.
13:30:00 Breakout Session 1 : (B) Mastering the Mechanics and Operational Challenges Associated With the Final DRA Rule Larri A Short, Esther R Scherb, Timothy J Nugent
15:00:00 Afternoon Refreshment Break
15:15:00 Breakout Session 2 : (D) Negative Pricing: When Statutory Discounts Create a Profit Center for Government Programs John D Shakow, Curtis Moore
15:15:00 Breakout Session 2 : (C) Countering Evolving Theories of Liability in AWP Cases Daniel “Dee” W Miles, III, Raymond C Winter, Jacques D Smith, Michael C Moore
16:15:00 Breakout Session 3 : (E) Grappling With The Uncertain Future of AWP: Preparing For the Changing Reimbursement Landscape Christopher Stomberg
16:15:00 Breakout Session 3 : (F) Creating a Robust Pricing Compliance/Audit Program That Will Provide the Most Accurate Calculations and the Ability to Verify Them Lena Robins
17:15:00 Conference Adjourns to Day 3
Thursday, March 12, 2009
08:00:00 Continental Breakfast
09:00:00 Co-Chairs’ Remarks
09:15:00 New Legislative and Regulatory Developments in Drug Pricing Steven Stranne, David L Ralston, Kathleen M Weldon, Tim Hermes
10:30:00 Morning Coffee Break
10:45:00 Identifying Pricing Related Government Enforcement Trends Mitchell J Lazris, Daniel R Miller, Virginia A Gibson, Riza Dagli
12:15:00 Networking Luncheon
13:30:00 Identifying New and Continuing OIG Target Areas Robert A Vito
14:30:00 Afternoon Refreshment Break
14:45:00 Antitrust Considerations in Pricing Scott A Stempel, John Roberti, Harvey Kaish
15:45:00 Insights Into 340B Legislative, Regulatory and Litigation Changes That Will Impact All Pricing Stakeholders Virginia A Gibson
16:45:00 Conference concludes
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.